Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Dairy Sci ; 107(9): 6817-6833, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-38762115

RESUMEN

The objective of this study was to determine the potential effect and interaction of 3-nitrooxypropanol (3-NOP; Bovaer, DSM-Firmenich Nutrition Products Ltd.) and whole cottonseed (WCS) on lactational performance and enteric methane (CH4) emission of dairy cows. A total of 16 multiparous cows, including 8 Holstein Friesian (HF) and 8 Brown Swiss (BS; 224 ± 36 DIM, 26 ± 3.7 kg milk yield, mean ± SD), were used in a split-plot design, where the main plot was the breed of cows. Within each subplot, cows were randomly assigned to a treatment sequence in a replicated 4 × 4 Latin square design with 2 × 2 factorial arrangements of treatments with four 24-d periods. The experimental treatments were as follows: (1) control (basal TMR), (2) 3-NOP (60 mg/kg TMR DM), (3) WCS (5% TMR DM), and (4) 3-NOP + WCS. The treatment diets were balanced for ether extract, crude protein, and NDF contents (4%, 16%, and 43% of TMR DM, respectively). The basal diets were fed twice daily at 0800 and 1800 h. Dry matter intake and milk yield were measured daily, and enteric gas emissions were measured (using the GreenFeed System, C-Lock Inc.) during the last 3 d of each 24-d experimental period when animals were housed in tiestalls. There was no difference in DMI on treatment level, whereas the WCS treatment increased ECM yield and milk fat yield. No interaction of 3-NOP and WCS occurred for any of the enteric gas emission parameters, but 3-NOP decreased CH4 production (g/d), CH4 yield (g/kg DMI), and CH4 intensity (g/kg ECM) by 13%, 14%, and 13%, respectively. Further, an unexpected interaction of breed by 3-NOP was observed for different enteric CH4 emission metrics: HF cows had a greater CH4 mitigation effect compared with BS cows for CH4 production (g/d; 18% vs. 8%), CH4 intensity (g/kg milk yield; 19% vs. 3%), and CH4 intensity (g/kg ECM; 19% vs. 4%). Hydrogen production was increased by 2.85-fold in HF and 1.53-fold in BS cows receiving 3-NOP. Further, a 3-NOP × time interaction occurred for both breeds. In BS cows, 3-NOP tended to reduce CH4 production by 18% at approximately 4 h after morning feeding, but no effect was observed at other time points. In HF cows, the greatest mitigation effect of 3-NOP (29.6%) was observed immediately after morning feeding, and it persisted at around 23% to 26% for 10 h until the second feed provision, and 3 h thereafter, in the evening. In conclusion, supplementing 3-NOP at 60 mg/kg DM to a high-fiber diet resulted in 18% to 19% reduction in enteric CH4 emission in Swiss HF cows. The lower response to 3-NOP by BS cows was unexpected and has not been observed in other studies. These results should be interpreted with caution due to the low number of cows per breed. Finally, supplementing WCS at 5% of DM improved ECM and milk fat yield but did not enhance the CH4 inhibition effect of 3-NOP of dairy cows.


Asunto(s)
Alimentación Animal , Dieta , Lactancia , Metano , Leche , Animales , Bovinos , Lactancia/efectos de los fármacos , Leche/química , Leche/metabolismo , Metano/biosíntesis , Metano/metabolismo , Femenino , Dieta/veterinaria , Propanoles/metabolismo , Gossypium
2.
Artículo en Ruso | MEDLINE | ID: mdl-10994106

RESUMEN

The dynamic study of 198 patients having virus hepatitides B and C was carried out. The etiological diagnosis in these patients had been made on the basis of serological investigation and the determination of markers with the use of the polymerase chain reaction. The manifestations of the disease were compared in 98 drug addicts and 100 patients stating they used no drugs. In addicts practicing the parenteral introduction of drugs acute virus hepatitides took, in most cases, the moderate course with the pain syndrome in the liver, abstinence symptoms, hepatomegaly, the elevated level of ALT in the blood. The convalescence period is characterized by the prolonged course with the slow restoration of the liver function.


Asunto(s)
Hepatitis B/diagnóstico , Hepatitis C/diagnóstico , Psicotrópicos , Abuso de Sustancias por Vía Intravenosa/diagnóstico , Enfermedad Aguda , Adolescente , Adulto , Alanina Transaminasa/sangre , Pruebas Enzimáticas Clínicas/estadística & datos numéricos , Femenino , Hepatitis B/etiología , Hepatitis C/etiología , Humanos , Ictericia/diagnóstico , Ictericia/etiología , Masculino , Abuso de Sustancias por Vía Intravenosa/complicaciones , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA